Loading clinical trials...

The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients | Clinical Trials | Clareo Health

COMPLETEDPHASE4

The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients

Open-label, Multicenter, Randomized Study to Assess the Efficacy and Safety of Celecoxib 200mg Capsule QD and Celecoxib 100mg BID in Hand Osteoarthritis Patients

NCT03067194•Chong Kun Dang Pharmaceutical

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate efficacy and safety of Celecoxib capsule in hand osteoarthritis patients.

Detailed Description

This is a six-weeks, open-label, multi-center, randomized study. Patients take Celecoxib 200mg capsule once a day or Celecoxib 100mg capsules twice per day. If patients do not tolerate the pain, they are able to take Acetaminophen as a rescue medication during 6 weeks.

Eligibility

Age

19 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Agreement with written informed consent and 19 years of age and older
•Patients history of OA of hand according to ACR criteria
•The 100mm Pain VAS is over 40mm

Exclusion Criteria

•History of OA of hand surgery
•Intra-articular injections within 3 months
•History of OA of hand infections within 3 months
•Who had taken a drug that has a control of result in clinical trial by investigator's decision
•Pregnant women, nursing mothers or Fertile women who not practice contraception with appropriate methods
•clinically significant hepatic, renal, cardiovascular diseases
•Any history of adverse reaction to the study drugs
•Patients with gastrointestinal ulcers or bleeding disorders
•Finger joint injury within 6 months
•Who had following results after examination
+7 more criteria

Locations (1)

Soon Chun Hyang University Hospital

Seoul, South Korea

Key Dates

Start Date

December 27, 2016

Primary Completion Date

July 10, 2017

Completion Date

November 20, 2018

Last Updated

January 30, 2020

Enrollment

117

ACTUAL participants

Conditions

Osteoarthritis Hand

Interventions

Celecoxib 100 MG

DRUG

Celecoxib 200mg

DRUG

Efficacy of Surgical Joint Denervation in Painful Digital Osteoarthritis

NCT05378841

Osteoarthritis Hand

View study

COMPLETEDNA

Embodied Virtual Reality for Chronic Pain

NCT05160038

Complex Regional Pain SyndromesComplex Regional Pain Syndrome Type I of the Upper Limb+7 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 30, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients

Inclusion Criteria

Exclusion Criteria

Efficacy of Surgical Joint Denervation in Painful Digital Osteoarthritis

Embodied Virtual Reality for Chronic Pain

Novel Splinting Technique Using 3D Models